PsiOxus is committed to developing our pipeline through the establishment of strategic partnerships with leading immuno-oncology companies and academic groups. We are currently seeking strategic immuno-oncology partners for our gene therapy virus products from our proprietary T-SIGn platform technology, including:

  • Collaborations on PsiOxus’ existing pipeline products
  • Research collaborations to develop novel T-SIGn virus programs including development of novel programs using proprietary partner genes or combinations of genes

For more information or inquiries on collaborations and partnerships, please contact


Strategic Collaborations

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image